NeoStem Inc Share Price Nyse
Equities
NBS
US6406503051
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
05-09 | Transcript : Lisata Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Lisata Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 23.63M 1.86B |
---|---|---|---|---|---|
Net income 2024 * | -25M -1.97B | Net income 2025 * | -30M -2.37B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.92
x | P/E ratio 2025 * |
-1.06
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.21% |
Latest transcript on NeoStem Inc
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.47% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
-1.62% | 11.98B |
- Stock Market
- Equities
- LSTA Stock
- NBS Stock